Citation Impact
Citing Papers
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
2008 Standout
Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Transfer learning for WiFi-based indoor localization
2008
Transferring localization models across space
2008
Testosterone Replacement and Resistance Exercise in HIV-Infected Men With Weight Loss and Low Testosterone Levels
2000
Reduced Serum Levels Of Clarithromycin In Patients Treated With Multi-Drug Regimens Including Rifampin Or Rifabutin For Mycobacterium Avium-M. Intracellulare Infection
1995
Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
2013 Standout
Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies
2003
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Adverse Events Associated with High-Dose Rifabutin in Macrolide-Containing Regimens for the Treatment of Mycobacterium avium Complex Lung Disease
1995
An Update and Review of Antiretroviral Therapy
2006
AIDS-Related Mycobacterium kansasii Infection with Initial Resistance to Clarithromycin
1998
A Randomized, Placebo‐Controlled Study of Rifabutin Added to a Regimen of Clarithromycin and Ethambutol for Treatment of Disseminated Infection with Mycobacterium avium Complex
1999
Initial (6-Month) Results of Three-Times-Weekly Azithromycin in Treatment Regimens for Mycobacterium avium Complex Lung Disease in Human Immunodeficiency Virus-Negative Patients
1998
Antibiotic Treatment ofChlamydia pneumoniaeafter Acute Coronary Syndrome
2005 Standout
NONTUBERCULOUS MYCOBACTERIAL INFECTIONS
1997
The Role of Advanced Generation Macrolides in the Prophylaxis and Treatment of Mycobacterium avium Complex (MAC) Infections
1997
A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection
1995
The Survival Benefits of AIDS Treatment in the United States
2006
Mycobacterium avium Complex in the Respiratory or Gastrointestinal Tract and the Risk of M. avium Complex Bacteremia in Patients with Human Immunodeficiency Virus Infection
1994
A Comparison of Two Regimens for the Treatment ofMycobacterium aviumComplex Bacteremia in AIDS: Rifabutin, Ethambutol, and Clarithromycin versus Rifampin, Ethambutol, Clofazimine, and Ciprofloxacin
1996
Azithromycin Activity Against Mycobacterium avium Complex Lung Disease in Patients Who Were Not Infected with Human Immunodeficiency Virus
1996
First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol
2001
Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis
2013 StandoutNobel
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
2010 Standout
Azithromycin for the Secondary Prevention of Coronary Events
2005
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Treatment Guidelines for HIV-Associated Wasting
2000
Once Weekly Azithromycin Therapy for Prevention ofMycobacterium aviumComplex Infection in Patients with AIDS: A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Trial
1998
Better Adherence with Once‐Daily Antiretroviral Regimens: A Meta‐Analysis
2009
Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis
2002
The therapeutic approach to non-tuberculous mycobacterial infection of the lung
2010
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Newly approved integrase inhibitors for clinical treatment of AIDS
2014
Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance
2006
Effects of nandrolone decanoate compared with placebo or testosterone on HIV‐associated wasting
2006
Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999
2000
Proinflammatory Cytokine and Human Immunodeficiency Virus RNA Levels during EarlyMycobacterium aviumComplex Bacteremia in Advanced AIDS
1998
Discontinuation of Prophylaxis againstMycobacterium aviumComplex Disease in HIV-Infected Patients Who Have a Response to Antiretroviral Therapy
2000
Emtricitabine
2005
Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic
1997
Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection
2000
Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS
1994
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Management of the metabolic effects of HIV and HIV drugs
2011
Declining incidence of AIDS-defining opportunistic illnesses
2012
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
2006 Standout
Structural Basis for the Antibiotic Activity of Ketolides and Azalides
2003 StandoutNobel
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
Applications of machine learning in drug discovery and development
2019 Standout
Dancing with chemical formulae of antivirals: A panoramic view (Part 2)
2013
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics
1997
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Nontuberculous Mycobacterial Infection in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
2004
Sustained Anabolic Effects of Long‐Term Androgen Administration in Men with AIDS Wasting
1999
Ribosomal antibiotics: structural basis for resistance, synergism and selectivity
2004 StandoutNobel
Cachexia and aging: An update based on the fourth international cachexia meeting
2009
The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States
2006
Itraconazole Prophylaxis for Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection: Randomized, Placebo‐Controlled, Double‐Blind Study
1999
New Drugs for Tuberculosis: Current Status and Future Prospects
2005
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Early Manifestations of DisseminatedMycobacterium aviumComplex Disease: A Prospective Evaluation
1997
Adipose Tissue as an Endocrine Organ
2004 Standout
DisseminatedMycobacterium aviumComplex Disease among Patients Infected with Human Immunodeficiency Virus, 1985–2000
2001
The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease
2001
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Risk Factors for Rifampin Mono-resistant Tuberculosis
1998
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
The Macrolides: Erythromycin, Clarithromycin, and Azithromycin
1999
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Antimicrobial susceptibility of coagulase-negative staphylococci
1994
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
23S rRNA base pair 2057–2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G
2005 StandoutNobel
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data
2012 Standout
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
1995
The macrolides
2002
Current and Emerging Azole Antifungal Agents
1999 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible Solutions
2012
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Carbamoyl Pyridone HIV-1 Integrase Inhibitors. 2. Bi- and Tricyclic Derivatives Result in Superior Antiviral and Pharmacokinetic Profiles
2013
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Approved Antiviral Drugs over the Past 50 Years
2016
Effects of Androgen Administration in Men with the AIDS Wasting Syndrome
1998
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
2020 Standout
Sensing meets mobile social networks
2008
Natural product and natural product derived drugs in clinical trials
2014 Standout
Epidemiology of infection by nontuberculous mycobacteria
1996
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Personal Sensing: Understanding Mental Health Using Ubiquitous Sensors and Machine Learning
2017
A Survey on Transfer Learning
2009 Standout
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Effects of Testosterone Replacement with a Nongenital, Transdermal System, Androderm, in Human Immunodeficiency Virus-Infected Men with Low Testosterone Levels1
1998
ANTIBIOTICS TARGETING RIBOSOMES: Resistance, Selectivity, Synergism, and Cellular Regulation
2005 StandoutNobel
Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination
1997 Standout
Guidelines for Treatment of Candidiasis
2004 Standout
Sarcopenia: European consensus on definition and diagnosis
2010 Standout
A Survey on Human Activity Recognition using Wearable Sensors
2012 Standout
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America
2007 Standout
Redesigning the string hash table, burst trie, and BST to exploit cache
2010
The Continuing Challenges of Leprosy
2006 Standout
Community-Guided Learning: Exploiting Mobile Sensor Users to Model Human Behavior
2010
Cache-efficient string sorting using copying
2007
A Conceptual Framework and a Toolkit for Supporting the Rapid Prototyping of Context-Aware Applications
2001 Standout
A survey of mobile phone sensing
2010 Standout
Works of Anthony LaMarca being referenced
Large-scale localization from wireless signal strength
2005
Recombinant Human Growth Hormone in Patients with HIV-Associated Wasting
1996
A Randomized Trial of Clarithromycin as Prophylaxis against DisseminatedMycobacterium aviumComplex Infection in Patients with Advanced Acquired Immunodeficiency Syndrome
1996
A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV
2004
Efficacy and Safety of Crofelemer for Noninfectious Diarrhea in HIV-Seropositive Individuals (ADVENT Trial): A Randomized, Double-Blind, Placebo-Controlled, Two-Stage Study
2013
Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDS
1993
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study
2011
Extending document management systems with user-specific active properties
2000
Recombinant Human Growth Hormone in Patients with HIV-Associated Wasting
1996
The Mobile Sensing Platform: An Embedded Activity Recognition System
2008
The influence of caches on the performance of heaps
1996
The Influence of Caches on the Performance of Sorting
1999